Stay updated on AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.

Latest updates to the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.4.2 has been added to the Study Record Versions. The previous revision v3.4.1 has been removed from the current history view.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.4.1 is added to the version history, and the older v3.4.0 entry is removed.SummaryDifference0.1%

- Check19 days agoChange DetectedA new revision entry v3.4.1 has been added to the record history and revision v3.4.0 has been removed. The Study Record Versions list has been updated to reflect these changes.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary visibility is added and change entries are now color-coded (green for additions, red for deletions). The revision label is updated to v3.4.0.SummaryDifference1%

- Check41 days agoChange DetectedThe record history adds a new version (v3.3.4) and reflects the removal of the previous version (v3.3.3).SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the Record History. The 'HHS Vulnerability Disclosure' link and 'Revision: v3.3.2' were removed.SummaryDifference0.2%

Stay in the know with updates to AK104 Monotherapy Plus Axitinib in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Monotherapy Plus Axitinib in RCC Clinical Trial page.